Market Trends
Key Emerging Trends in the Respiratory Inhalers Market
The increasing number of people facing chronic respiratory diseases is a major reason for the growth of the global respiratory inhalers market. It's anticipated that more people will experience respiratory disorders like asthma, COPD, and others in the future, leading to a higher demand for these devices. Currently, about 6.4% of Americans have COPD, and in the U.K., around 5.4 million people have asthma. The number of cases is expected to rise in developing countries and worldwide, increasing the demand for these inhalers. According to the Forum of International Respiratory Societies, young children and infants are especially vulnerable to respiratory diseases, with around 9.0 million children under the age of 5 years dying each year, many of them due to lung diseases.
Another factor driving the growth of the respiratory inhalers market is the increasing use of combination therapy. In recent years, patients have been opting for combined therapies like bronchodilator therapy for treating COPD and other conditions. This shift is because combined therapies offer additional benefits, such as being more reliable in complex cases, increased effectiveness, and easier reimbursement policies associated with the therapy. It's also observed that these combination therapies are more effective for the long-term control of COPD and other respiratory diseases. Although these therapies cost more compared to conventional ones, they are particularly beneficial for patients with complex respiratory conditions. The rise in the usage of combination therapies, including triple combination therapy for COPD patients, is expected to drive the growth of the global respiratory inhaler devices market in the coming years.
Leave a Comment